Bruker [BRKR] vs Globus Medical [GMED] Detailed Stock Comparison
Bruker
NASDAQ
Loading...
Globus Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Bruker wins in 5 metrics, Globus Medical wins in 14 metrics, with 0 ties. Globus Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bruker | Globus Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 58.52 | 43.77 | Globus Medical |
| Price-to-Book Ratio | 2.56 | 1.84 | Globus Medical |
| Debt-to-Equity Ratio | 132.75 | 2.83 | Globus Medical |
| PEG Ratio | 11.23 | 17.15 | Bruker |
| EV/EBITDA | 12.66 | 10.62 | Globus Medical |
| Profit Margin (TTM) | 2.31% | 13.58% | Globus Medical |
| Operating Margin (TTM) | 3.61% | 17.33% | Globus Medical |
| EBITDA Margin (TTM) | 3.61% | 17.33% | Globus Medical |
| Return on Equity | 4.07% | 8.62% | Globus Medical |
| Return on Assets (TTM) | 3.55% | 5.82% | Globus Medical |
| Free Cash Flow (TTM) | $136.00M | $405.21M | Globus Medical |
| 1-Year Return | -50.92% | -19.88% | Globus Medical |
| Price-to-Sales Ratio (TTM) | 1.37 | 3.02 | Bruker |
| Enterprise Value | $7.06B | $7.81B | Globus Medical |
| EV/Revenue Ratio | 2.05 | 2.98 | Bruker |
| Gross Profit Margin (TTM) | 44.88% | 67.33% | Globus Medical |
| Revenue per Share (TTM) | $23 | $19 | Bruker |
| Earnings per Share (Diluted) | $0.52 | $1.34 | Globus Medical |
| Beta (Stock Volatility) | 1.16 | 1.20 | Bruker |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Bruker vs Globus Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bruker | -2.34% | -19.90% | -28.16% | -24.88% | -40.49% | -48.26% |
| Globus Medical | 8.47% | 11.42% | 3.62% | -19.06% | -32.88% | -28.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bruker | -50.92% | -50.77% | -29.45% | 51.09% | 133.72% | 644.01% |
| Globus Medical | -19.88% | -12.03% | 6.93% | 121.15% | 334.44% | 334.44% |
Performance & Financial Health Analysis: Bruker vs Globus Medical
| Metric | BRKR | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $4.73B | $7.92B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 4,297,610 | 1,536,240 |
| 90 Day Avg. Volume | 3,660,770 | 1,652,257 |
| Last Close | $30.43 | $58.65 |
| 52 Week Range | $30.19 - $72.94 | $51.79 - $94.93 |
| % from 52W High | -58.28% | -38.22% |
| All-Time High | $94.86 (Mar 18, 2024) | $94.93 (Jan 27, 2025) |
| % from All-Time High | -67.92% | -38.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.18% |
| Quarterly Earnings Growth | 0.00% | 5.39% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.14% |
| Operating Margin (TTM) | 0.04% | 0.17% |
| Return on Equity (TTM) | 0.04% | 0.09% |
| Debt to Equity (MRQ) | 132.75 | 2.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.89 | $31.81 |
| Cash per Share (MRQ) | $0.65 | $1.70 |
| Operating Cash Flow (TTM) | $165.90M | $669.16M |
| Levered Free Cash Flow (TTM) | $223.20M | $456.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Bruker vs Globus Medical
| Metric | BRKR | GMED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 58.52 | 43.77 |
| Forward P/E | 11.23 | 17.15 |
| PEG Ratio | 11.23 | 17.15 |
| Price to Sales (TTM) | 1.37 | 3.02 |
| Price to Book (MRQ) | 2.56 | 1.84 |
| Market Capitalization | ||
| Market Capitalization | $4.73B | $7.92B |
| Enterprise Value | $7.06B | $7.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.05 | 2.98 |
| Enterprise to EBITDA | 12.66 | 10.62 |
| Risk & Other Metrics | ||
| Beta | 1.16 | 1.20 |
| Book Value per Share (MRQ) | $11.89 | $31.81 |
Financial Statements Comparison: Bruker vs Globus Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BRKR | GMED |
|---|---|---|
| Revenue/Sales | $801.40M | $598.12M |
| Cost of Goods Sold | $410.20M | $195.40M |
| Gross Profit | $391.20M | $402.72M |
| Research & Development | $97.10M | $33.06M |
| Operating Income (EBIT) | $65.70M | $98.06M |
| EBITDA | $118.60M | $160.92M |
| Pre-Tax Income | $25.10M | $103.67M |
| Income Tax | $8.70M | $28.21M |
| Net Income (Profit) | $16.80M | $75.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BRKR | GMED |
|---|---|---|
| Cash & Equivalents | $184.20M | $461.27M |
| Total Current Assets | $2.11B | $1.71B |
| Total Current Liabilities | $1.34B | $384.70M |
| Long-Term Debt | $2.08B | $81.69M |
| Total Shareholders Equity | $1.85B | $4.09B |
| Retained Earnings | $2.42B | $1.04B |
| Property, Plant & Equipment | N/A | $1.06B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BRKR | GMED |
|---|---|---|
| Operating Cash Flow | $55.70M | $193.84M |
| Capital Expenditures | $-26.00M | $-36.10M |
| Free Cash Flow | $39.00M | $136.20M |
| Debt Repayment | $-175.60M | $-449.99M |
| Common Stock Repurchase | $-10.00M | $-190.45M |
Short Interest & Institutional Ownership Analysis
| Metric | BRKR | GMED |
|---|---|---|
| Shares Short | 9.45M | 4.52M |
| Short Ratio | 3.44 | 3.01 |
| Short % of Float | 0.13% | 0.04% |
| Average Daily Volume (10 Day) | 4,297,610 | 1,536,240 |
| Average Daily Volume (90 Day) | 3,660,770 | 1,652,257 |
| Shares Outstanding | 151.68M | 137.42M |
| Float Shares | 103.13M | 111.79M |
| % Held by Insiders | 0.32% | 0.01% |
| % Held by Institutions | 0.83% | 1.02% |
Dividend Analysis & Yield Comparison: Bruker vs Globus Medical
| Metric | BRKR | GMED |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |